Quest Diagnostics holds the cleaner structural position, with the lead spread across growth and stability. Elevance Health still has the edge on profitability, which keeps the comparison from looking entirely one-sided. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.
The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the S&P 500 universe, making them directly comparable.
This is not just a one-metric split: both growth and stability materially support the lead. Quest Diagnostics Incorporated leads by 13 points on the overall comparison score.
This pair is matched through long-term financial trajectory similarity within the selected peer universe.
The pair sits on a clearly comparable long-term path, though it is not a near-twin match.
The clearest structural overlap shows up in margin consistency and investment intensity.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
Score differences across key dimensions.
Left means cheaper relative valuation. Higher means stronger structure.
Quest Diagnostics Incorporated is stronger, but the price setup still looks more supportive for Elevance Health, Inc..
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Where DGX and ELV each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
Earnings growth is one contributing factor within the growth lead.
Capital efficiency also runs the other way, with a 8.6-point ROIC edge acting as a real counterforce.
The lead is built on both growth and stability — though profitability still provides a counterweight.
Break down the DGX vs ELV comparison across all dimensions with the full interactive tool.
Explore how DGX and ELV each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.